Metachronous early gastric cancer over a period of 13 years after eradication of Helicobacter pylori

被引：4

作者：

Mitsunaga A. ^{[1
]}

Tagata T. ^{[1
]}

Hamano T. ^{[1
]}

Teramoto H. ^{[1
]}

Kan M. ^{[2
]}

Mitsunaga Y. ^{[2
]}

Tobari M. ^{[2
]}

Shirato I. ^{[2
]}

Shirato M. ^{[2
]}

Yoshida S. ^{[2
]}

Shimada M. ^{[2
]}

Nishino T. ^{[2
]}

机构：

[1] Department of Endoscopy, Tokyo Women’s Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo, 276-8524, Chiba

[2] Department of Gastroenterology, Tokyo Women’s Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo, 276-8524, Chiba

来源：

Clinical Journal of Gastroenterology | 2014年 / 7卷 / 6期

关键词：

Early gastric cancer; Endoscopic treatment; Eradication; Helicobacter pylori; Metachronous cancer;

D O I：

10.1007/s12328-014-0536-9

中图分类号：

学科分类号：

摘要：

Stomach cancer can occur during chronic inflammation from Helicobacter pylori (HP) infection, and its occurrence can be suppressed by eradication of HP. However, the effects of suppressing stomach cancer by HP eradication are limited, and the cancer is known to recur even after eradication of this infection. Here, we report the case of a 56-year-old male patient with gastric cancer who, although undergoing HP eradication after treatment of early gastric cancer with endoscopy, experienced five metachronous cancer recurrences over a period of 13 years. Whether observation of patients who undergo eradication of HP due to peptic ulcers or chronic gastritis and patients who undergo eradication after endoscopic treatment for early gastric cancer should be performed at the same interval is an issue that must be addressed in the future. The appropriate observation period for each patient must be established while considering the burdens to the patient and from the medical economic perspective. © 2014, The Author(s).

引用

页码：490 / 495

页数：5

共 14 条

[1] Fukase K., Kato M., Kikuchi S., Japan Gast Study Group, Et al., Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, Lancet, 372, pp. 392-397, (2008)
[2] Seo J.Y., Lee D.H., Cho Y., Et al., Eradication of Helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer, Hepatogastroenterology, 60, pp. 776-780, (2013)
[3] Kwon Y.H., Heo J., Lee H.S., Et al., Failure of Helicobacter eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients, Aliment Pharmacol Ther, 39, pp. 609-618, (2014)
[4] Take S., Mizuno M., Ishiki K., Et al., The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori, J Gastroenterol, 46, pp. 318-324, (2011)
[5] Marshall B.J., Warren J.R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration, Lancet, 1, pp. 1311-1315, (1984)
[6] Miyamoto M., Haruma K., Gastric ulcer and duodenal ulcer, Nihon Rinsho, 71, pp. 1418-1423, (2013)
[7] Uemura N., Okamoto S., Yamamoto S., Et al., Helicobacter pylori infection and the development of gastric cancer, N Engl J Med, 345, pp. 784-789, (2001)
[8] Choi J., Kim S.G., Yoon H., Et al., Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma, Clin Gastroenterol Hepatol, 12, pp. 793-800, (2014)
[9] Kato M., Nishida T., Yamamoto K., Et al., Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group, Gut, 62, pp. 1425-1432, (2013)
[10] Bae S.E., Jung H.Y., Kang J., Et al., Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm, Am J Gastroenterol, 109, pp. 60-67, (2014)

← 1 2 →